“ Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia ”, Braz. J. Pharm. Sci., vol. 52, no. 4, pp. 581–589, Dec. 2016, doi: 10.1590/s1984-82502016000400001.